Skip to main content
logo
Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.26
+0.15 (2.11%)
Jul 31, 2026, 4:08 PM HKT

HKG:2591 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Revenue
131.51131.51--
Revenue Growth
132.98%---
Gross Profit
117.06117.06--
Operating Income
-346.87-346.87-189.42-747.91
Net Income
-341.36-341.36-174.69-733.38
Earnings Per Share
-0.79-0.79-0.42-1.92
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
1,2051,205796.85695.31
Total Debt
166.26166.269.946.59
Net Cash (Debt)
1,0381,038786.95648.73
Net Cash Growth
53.35%31.94%21.31%-
Net Cash Per Share
2.392.391.881.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-295.54-295.54-162.62-164.6
Capital Expenditures
-19.97-19.97-3.95-12.05
Free Cash Flow
-315.51-315.51-166.57-176.64
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Gross Margin
89.01%89.01%--
Operating Margin
-263.76%-263.76%--
Pretax Margin
-259.57%-259.57%--
Profit Margin
-259.57%-259.57%--
FCF Margin
-239.91%-239.91%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
22.6695.64--